论文部分内容阅读
曲普瑞林是一种人工合成高效激动剂型类似物。该药由德国Debipharm公司开发,于1975年申请美国专利,1976年申请德国专利,1986年首次在德国上市,我国尚未有进口及生产,且该药巳超过专利保护期。曲普瑞林的适当剂量给药可促进或抑制性激素分泌,因此,此类药物可用于治疗前列腺癌、子宫癌、乳腺癌、子宫内膜异位等疾病。据文献报导,每天2×100ug治疗六个月,效果与
Triptorelin is a synthetic high-potency agonist analogue. The drug was developed by the German company Debipharm, applied for a U.S. patent in 1975, applied for a German patent in 1976, was first listed in Germany in 1986, and has not yet been imported or manufactured in China. The drug has surpassed the patent protection period. The appropriate dose of triptorelin can promote or inhibit the secretion of sex hormones, therefore, these drugs can be used for the treatment of prostate cancer, uterine cancer, breast cancer, endometriosis and other diseases. According to the literature, 2 × 100ug daily treatment for six months, the effect and